MTOR and neoplasm: The percentages of CD11b+ Ly6Chigh monocytic cells in the peripheral blood, spleens and tumor mass of Lyzs-mTOR KO mice were significantly lower than those in WT recipients (P < 0.001, Fig. 3C–F).